WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010025541) IDENTIFICATION OF A CONSERVED INNER CORE OLIGOSACCHARIDE REGION OF MORAXELLA CATARRHALIS LIPOPOLYSACCHARIDE AS A VACCINE ANTIGEN
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/025541    International Application No.:    PCT/CA2009/001193
Publication Date: 11.03.2010 International Filing Date: 04.09.2009
IPC:
C08B 37/00 (2006.01), A61K 39/00 (2006.01), A61K 39/385 (2006.01), A61P 31/04 (2006.01), A61P 37/04 (2006.01), C07K 16/12 (2006.01), A61K 39/104 (2006.01), C12P 21/08 (2006.01), A61K 31/739 (2006.01)
Applicants: NATIONAL RESEARCH COUNCIL OF CANADA [CA/CA]; Building M 58, 1200 Montreal Road Ottawa, Ontario K1A 0R6 (CA) (For All Designated States Except US).
COX , Andrew, D. [CA/CA]; (CA) (For US Only).
RICHARDS , James, C . [CA/CA]; (CA) (For US Only)
Inventors: COX , Andrew, D.; (CA).
RICHARDS , James, C .; (CA)
Agent: BATTISON WILLIAMS DUPUIS; 2157 Henderson Hwy. Winnipeg , Manitoba R2G 1P9 (CA)
Priority Data:
61/094,098 04.09.2008 US
Title (EN) IDENTIFICATION OF A CONSERVED INNER CORE OLIGOSACCHARIDE REGION OF MORAXELLA CATARRHALIS LIPOPOLYSACCHARIDE AS A VACCINE ANTIGEN
(FR) IDENTIFICATION D'UNE ZONE D'OLIGOSACCHARIDE A NOYAU INTERNE CONSERVE DE LIPOPOLYSACCHARIDE DE MORAXELLA CATARRHALIS COMME ANTIGENE VACCINAL
Abstract: front page image
(EN)There are disclosed herein antigenic structures useful in producing vaccines against and compounds helpful in combating diseases caused by the bacterium Moraxella catarrhalis. Disclosed are specific structures of the carbohydrate molecules derived from genetically engineered strains of Moraxella catarrhalis, which when presented appropriately to the immune system will facilitate a functional immune response to the target core oligosaccharide region.
(FR)L'invention concerne des structures antigéniques utiles dans la production de vaccins et de composés contre des maladies causées par la bactérie Moraxella catarrhalis. L'invention concerne également des structures spécifiques des molécules glucidiques issues de souches génétiquement modifiées de Moraxella catarrhalis qui, lorsqu'elles sont présentées de façon idoine au système immunitaire, favorisent une réponse immunitaire fonctionnelle à la zone d'oligosaccharide à noyau cible.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)